Approaches to improving the kinetics of adenovirus-delivered genes and gene products

Advanced Drug Delivery Reviews

Volumn 57, Issue 5, 2005, Pages 781-802

  Xu, Zhi Li ^a   Mizuguchi, Hiroyuki ^a   Sakurai, Fuminori ^a   Koizumi, Naoya ^a   Hosono, Tetsuji ^a   Kawabata, Kenji ^a   Watanabe, Yoshiteru ^b   Yamaguchi, Teruhide ^a   Hayakawa, Takao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Biodistribution; Cationic liposome; Helper dependent; Immunogenic toxicities; In cis acting element; Integration; PEGylation; Regulatable expression; Targeting

Indexed keywords

DRUG PRODUCTS; REACTION KINETICS; TOXICITY; VECTORS; VIRUSES;

ADENOVIRUS (AD); GENE PRODUCTS; GENE THERAPY; READMINISTRATION;

GENES;

ADENOVIRUS VECTOR; DRUG CARRIER;

CLINICAL TRIAL; DISSEMINATED INTRAVASCULAR CLOTTING; FEVER; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HUMAN; IMMUNOPATHOLOGY; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROTYPE; SIDE EFFECT; TRANSGENE;

ADENOVIRIDAE; ANIMALS; DRUG DELIVERY SYSTEMS; GENE THERAPY; GENETIC VECTORS; HUMANS;

EID: 14844283783     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2004.12.010     Document Type: Review

References (188)

1. J.M. Weber, B.G. Talbot, and L. Delorme The orientation of the adenovirus fiber and its anchor domain identified through molecular mimicry Virology 168 1989 180 182
2. N.M. Green, N.G. Wrigley, W.C. Russell, S.R. Martin, and A.D. McLachlan Evidence for a repeating cross-beta sheet structure in the adenovirus fibre EMBO J. 2 1983 1357 1365
3. L.J. Henry, D. Xia, M.E. Wilke, J. Deisenhofer, and R.D. Gerard Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli J. Virol. 68 1994 5239 5246
4. N. Louis, P. Fender, A. Barge, P. Kitts, and J. Chroboczek Cell-binding domain of adenovirus serotype 2 fiber J. Virol. 68 1994 4104 4106
5. F.L. Graham, J. Smiley, W.C. Russell, and R. Nairn Characteristics of a human cell line transformed by DNA from human adenovirus type 5 J. Gen. Virol. 36 1977 59 74
6. F.J. Fallaux, O. Kranenburg, S.J. Cramer, A. Houweling, H. Van Ormondt, R.C. Hoeben, and A.J. Van Der Eb Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors Hum. Gene Ther. 7 1996 215 222
7. F.J. Fallaux, A. Bout, I. van der Velde, D.J. van den Wollenberg, K.M. Hehir, J. Keegan, C. Auger, S.J. Cramer, H. van Ormondt, A.J. van der Eb, D. Valerio, and R.C. Hoeben New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses Hum. Gene Ther. 9 1998 1909 1917
8. A.J. Bett, W. Haddara, L. Prevec, and F.L. Graham An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3 Proc. Natl. Acad. Sci. U. S. A. 91 1994 8802 8806
9. A.J. Bett, L. Prevec, and F.L. Graham Packaging capacity and stability of human adenovirus type 5 vectors J. Virol. 67 1993 5911 5921
10. J.M. Bergelson, J.A. Cunningham, G. Droguett, E.A. Kurt-Jones, A. Krithivas, J.S. Hong, M.S. Horwitz, R.L. Crowell, and R.W. Finberg Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 Science 275 1997 1320 1323
11. R.P. Tomko, R. Xu, and L. Philipson HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses Proc. Natl. Acad. Sci. U. S. A. 94 1997 3352 3356
12. P.W. Roelvink, A. Lizonova, J.G. Lee, Y. Li, J.M. Bergelson, R.W. Finberg, D.E. Brough, I. Kovesdi, and T.J. Wickham The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F J. Virol. 72 1998 7909 7915
13. T.J. Wickham, P. Mathias, D.A. Cheresh, and G.R. Nemerow Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment Cell 73 1993 309 319
14. E. Davison, R.M. Diaz, I.R. Hart, G. Santis, and J.F. Marshall Integrin alpha5beta1-mediated adenovirus infection is enhanced by the integrin-activating antibody TS2/16 J. Virol. 71 1997 6204 6207
15. E. Li, S.L. Brown, D.G. Stupack, X.S. Puente, D.A. Cheresh, and G.R. Nemerow Integrin alpha(v)beta1 is an adenovirus coreceptor J. Virol. 75 2001 5405 5409
16. M.C. Dechecchi, P. Melotti, A. Bonizzato, M. Santacatterina, M. Chilosi, and G. Cabrini Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5 J. Virol. 75 2001 8772 8780
17. P. Seth, D.J. Fitzgerald, M.C. Willingham, and I. Pastan Role of a low-pH environment in adenovirus enhancement of the toxicity of a Pseudomonas exotoxin-epidermal growth factor conjugate J. Virol. 51 1984 650 655
18. U.F. Greber, M. Willetts, P. Webster, and A. Helenius Stepwise dismantling of adenovirus 2 during entry into cells Cell 75 1993 477 486
19. J.M. Isner, and T. Asahara Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization J. Clin. Invest. 103 1999 1231 1236
20. J.M. Isner Myocardial gene therapy Nature 415 2002 234 239
21. R. Alemany, C. Balague, and D.T. Curiel Replicative adenoviruses for cancer therapy Nat. Biotechnol. 18 2000 723 727
22. Q. Liu, and D.A. Muruve Molecular basis of the inflammatory response to adenovirus vectors Gene Ther. 10 2003 935 940
23. K. Jooss, and N. Chirmule Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy Gene Ther. 10 2003 955 963
24. D. Chen, B. Murphy, R. Sung, and J.S. Bromberg Adaptive and innate immune responses to gene transfer vectors: role of cytokines and chemokines in vector function Gene Ther. 10 2003 991 998
25. G.J. Clesham, P.J. Adam, D. Proudfoot, P.D. Flynn, S. Efstathiou, and P.L. Weissberg High adenoviral loads stimulate NF kappaB-dependent gene expression in human vascular smooth muscle cells Gene Ther. 5 1998 174 180
26. A. Lieber, C.-Y. He, L. Meuse, D. Schowalter, I. Kirillova, B. Winther, and M.A. Kay The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors J. Virol. 71 1997 8798 8807
27. K.B. Elkon, C.C. Liu, J.G. Gall, J. Trevejo, M.W. Marino, K.A. Abrahamsen, X. Song, J.L. Zhou, L.J. Old, R.G. Crystal, and E. Falck-Pedersen Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors Proc. Natl. Acad. Sci. U. S. A. 94 1997 9814 9819
28. Y. Zhang, N. Chirmule, G.P. Gao, R. Qian, M. Croyle, B. Joshi, J. Tazelaar, and J.M. Wilson Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages Molec. Ther. 3 2001 697 707
29. M.A. Schnell, Y. Zhang, J. Tazelaar, G.P. Gao, Q.C. Yu, R. Qian, S.J. Chen, A.N. Varnavski, C. LeClair, S.E. Raper, and J.M. Wilson Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors Molec. Ther. 3 2001 708 722
30. L.R. Gooding Regulation of TNF-mediated cell death and inflammation by human adenoviruses Infect. Agents Dis. 3 1994 106 115
31. C.E. Thomas, D. Birkett, I. Anozie, M.G. Castro, and P.R. Lowenstein Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain Molec. Ther. 3 2001 36 46
32. N. Morral, W.K. O'Neal, K. Rice, M.M. Leland, P.A. Piedra, E. Aguilar-Cordova, K.D. Carey, A.L. Beaudet, and C. Langston Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons Hum. Gene Ther. 13 2002 143 154
33. E. Marshall Gene therapy death prompts review of adenovirus vector Science 286 1999 2244 2245
34. Assessment of adenoviral vector safety and toxicity: report of the National Institute of Health Recombinant DNA Advisory Committee Hum. Gene Ther. 13 2002 3 13
35. A. Kirn, J.P. Gut, and J.L. Gendrault Interaction of viruses with sinusoidal cells Prog. Liver Dis. 7 1982 377 392
36. P.B. Jahrling, and G.A. Eddy Comparisons among members of the Venezuelan encephalitis virus complex using hydroxylapatite column chromatography Am. J. Epidemiol. 106 1977 408 417
37. M.M. Hitt, C.L. Addison, and F.L. Graham Human adenovirus vectors for gene transfer into mammalian cells Adv. Pharmacol. 40 1997 137 206
38. R. Alemany, K. Suzuki, and D.T. Curiel Blood clearance rates of adenovirus type 5 in mice J. Gen. Virol. 81 2000 2605 2609
39. G. Wolff, S. Worgall, N. van-Rooijen, W.R. Song, B.G. Harvey, and R.G. Crystal Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ J. Virol. 71 1997 624 629
40. S. Worgall, G. Wolff, E. Falck-Pedersen, and R.G. Crystal Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration Hum. Gene. Ther. 8 1997 37 44
41. F. Sakurai, H. Mizuguchi, T. Yamaguchi, and T. Hayakawa Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector Molec. Ther. 8 2003 813 821
42. N. Koizumi, H. Mizuguchi, F. Sakurai, T. Yamaguchi, Y. Watanabe, and T. Hayakawa Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and αv integrin-binding ablation J. Virol. 77 2003 13062 13072
43. D.A. Einfeld, R. Schroeder, P.W. Roelvink, A. Lizonova, C.R. King, I. Kovesdi, and T.J. Wickham Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions J. Virol. 75 2001 11284 11291
44. H. Fechner, A. Haack, H. Wang, X. Wang, K. Eizema, M. Pauschinger, R. Schoemaker, R. Veghel, A. Houtsmuller, H.P. Schultheiss, J. Lamers, and W. Poller Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers Gene Ther. 6 1999 1520 1535
45. N. Tao, G.P. Gao, M. Parr, J. Johnston, T. Baradet, J.M. Wilson, J. Barsoum, and S.E. Fawell Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver Molec. Ther. 3 2001 28 35
46. R.J. Ziegler, C. Li, M. Cherry, Y. Zhu, D. Hempel, N. van Rooijen, Y.A. Ioannou, R.J. Desnick, M.A. Goldberg, N.S. Yew, and S.H. Cheng Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry disease Hum. Gene Ther. 13 2002 935 945
47. D. Barr, J. Tubb, D. Ferguson, A. Scaria, A. Lieber, C. Wilson, J. Perkins, and M.A. Kay Strain related variations in adenoviral-mediated transgene expression from mouse hepatocytes in vivo: comparisions between immunocompetent and immunodeficient inbred strains Gene Ther. 2 1995 151 154
48. D.B. Schowalter, C.L. Himeda, B.L. Winther, C.B. Wilson, and M.A. Kay Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice J. Virol. 73 1999 4755 4766
49. M. Lusky, M. Christ, K. Rittner, A. Dieterle, D. Dreyer, B. Mourot, H. Schultz, F. Stoeckel, A. Pavirani, and M. Mehtali In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted J. Virol. 72 1998 2022 2032
50. W.K. O'Neal, H. Zhou, N. Morral, E. Aguilar-Cordova, J. Pestaner, C. Langston, B. Mull, Y. Wang, A.L. Beaudet, and B. Lee Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery Hum. Gene Ther. 9 1998 1587 1598
51. J.L. Andrews, M.J. Kadan, M.I. Gorziglia, M. Kaleko, and S. Connelly Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII Molec. Ther. 3 3 2001 329 336
52. S. Kochanek, G. Schiedner, and C. Volpers High-capacity 'gutless' adenoviral vectors Curr. Opin. Mol. Ther. 3 2001 454 463
53. I.H. Kim, A. Józkowicz, P.A. Piedra, K. Oka, and L. Chan Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector Proc. Natl. Acad. Sci. U. S. A. 98 2001 13282 13287
54. P.S. Reddy, K. Sakhuja, S. Ganesh, L. Yang, D. Kayda, T. Brann, S. Pattison, D. Golightly, N. Idamakanti, A. Pinkstaff, M. Kaloss, C. Barjot, J.S. Chamberlain, M. Kaleko, and S. Connelly Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector Molec. Ther. 5 2002 63 73
55. M.K. Chuah, G. Schiedner, L. Thorrez, B. Brown, M. Johnston, V. Gillijns, S. Hertel, N. Van Rooijen, D. Lillicrap, D. Collen, T. VandenDriessche, and S. Kochanek Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors Blood 101 2003 1734 1743
56. A. Ehrhardt, H. Xu, A.M. Dillow, D.A. Bellinger, T.C. Nichols, and M.A. Kay A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia Blood 102 2003 2403 2411
57. A. Ehrhardt, and M.A. Kay A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo Blood 99 2002 3923 3930
58. K. Sakhuja, P.S. Reddy, S. Ganesh, F. Cantaniag, S. Pattison, P. Limbach, D.B. Kayda, M.J. Kadan, M. Kaleko, and S. Connelly Optimization of the generation and propagation of gutless adenoviral vectors Hum. Gene Ther. 14 2003 243 254
59. R.J. Parks, L. Chen, M. Anton, U. Sankar, M.A. Rudnicki, and F.L. Graham A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal Proc. Natl. Acad. Sci. U. S. A. 93 1996 13565 13570
60. D. Yee, S.E. McGuire, N. Brunner, T.W. Kozelsky, D.C. Allred, S.H. Chen, and S.L. Woo Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer Hum. Gene Ther. 7 1996 1251 1257
61. F. Lohr, Q. Huang, K. Hu, M.W. Dewhirst, and C.Y. Li Systemic vector leakage and transgene expression by intratumorally injected recombinant adenovirus vectors Clin. Cancer Res. 7 2001 3625 3628
62. H. Mizuguchi, and T. Hayakawa Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase Cancer Gene Ther. 9 2002 236 242
63. D.H. Sterman, J. Treat, L.A. Litzky, K.M. Amin, L. Coonrod, K. Molnar-Kimber, A. Recio, L. Knox, J.M. Wilson, S.M. Albelda, and L.R. Kaiser Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma Hum. Gene Ther. 9 1998 1083 1092
64. C.R. Miller, D.J. Buchsbaum, P.N. Reynolds, J.T. Douglas, G.Y. Gillespie, M.S. Mayo, D. Raben, and D.T. Curiel Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer Cancer Res. 58 1998 5738 5748
65. Y. Li, R.C. Pong, J.M. Bergelson, M.C. Hall, A.I. Sagalowsky, C.P. Tseng, Z. Wang, and J.T. Hsieh Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy Cancer Res. 59 1999 325 330
66. T. Okegawa, Y. Li, R.C. Pong, J.M. Bergelson, J. Zhou, and J.T. Hsieh The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy Cancer Res. 60 2000 5031 5036
67. J. Nalbantoglu, G. Pari, G. Karpati, and P.C. Holland Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells Hum. Gene Ther. 10 1999 1009 1019
68. T.J. Wickham, P.W. Roelvink, D.E. Brough, and I. Kovesdi Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types Nat. Biotechnol. 14 1996 1570 1573
69. T.J. Wickham, E. Tzeng, L.L.n. Shears, P.W. Roelvink, Y. Li, G.M. Lee, D.E. Brough, A. Lizonova, and I. Kovesdi Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins J. Virol. 71 1997 8221 8229
70. R.G. Crystal, N.G. McElvaney, M.A. Rosenfeld, C.S. Chu, A. Mastrangeli, J.G. Hay, S.L. Brody, H.A. Jaffe, N.T. Eissa, and C. Danel Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis (see comments) Nat. Genet. 8 1994 42 51
71. J. Zabner, P. Freimuth, A. Puga, A. Fabrega, and M.J. Welsh Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection J. Clin. Invest. 100 1997 1144 1149
72. R.J. Pickles, D. McCarty, H. Matsui, P.J. Hart, S.H. Randell, and R.C. Boucher Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer J. Virol. 72 1998 6014 6023
73. R.P. Leon, T. Hedlund, S.J. Meech, S. Li, J. Schaack, S.P. Hunger, R.C. Duke, and J. DeGregori Adenoviral-mediated gene transfer in lymphocytes Proc. Natl. Acad. Sci. U. S. A. 95 1998 13159 13164
74. S. Huang, R.I. Endo, and G.R. Nemerow Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery J. Virol. 69 1995 2257 2263
75. C. Hidaka, E. Milano, P.L. Leopold, J.M. Bergelson, N.R. Hackett, R.W. Finberg, T.J. Wickham, I. Kovesdi, P. Roelvink, and R.G. Crystal CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts J. Clin. Invest. 103 1999 579 587
76. D.M. Shayakhmetov, T. Papayannopoulou, G. Stamatoyannopoulos, and A. Lieber Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector J. Virol. 74 2000 2567 2583
77. B.W. Tillman, T.D. de Gruijl, S.A. Luykx-de Bakker, R.J. Scheper, H.M. Pinedo, T.J. Curiel, W.R. Gerritsen, and D.T. Curiel Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector J. Immunol. 162 1999 6378 6383
78. N. Okada, Y. Tsukada, S. Nakagawa, H. Mizuguchi, K. Mori, T. Saito, T. Fujita, A. Yamamoto, T. Hayakawa, and T. Mayumi Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors Biochem. Biophys. Res. Commun. 282 2001 173 179
79. T.J. Wickham Targeting adenovirus Gene Ther. 7 2000 110 114
80. B.G. Barnett, C.J. Crews, and J.T. Douglas Targeted adenoviral vectors Biochim. Biophys. Acta 1575 2002 1 14
81. T.A. Smith, N. Idamakanti, M.L. Rollence, J. Marshall-Neff, J. Kim, K. Mulgrew, G.R. Nemerow, M. Kaleko, and S.C. Stevenson Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice Hum. Gene Ther. 14 2003 777 787
82. J.T. Douglas, B.E. Rogers, M.E. Rosenfeld, S.I. Michael, M. Feng, and D.T. Curiel Targeted gene delivery by tropism-modified adenoviral vectors Nat. Biotechnol. 14 1996 1574 1578
83. B.A. Sosnowski, D.L. Gu, M. D'Andrea, J. Doukas, and G.F. Pierce FGF2-targeted adenoviral vectors for systemic and local disease Curr. Opin. Mol. Ther. 1 1999 573 579
84. C.K. Goldman, B.E. Rogers, J.T. Douglas, B.A. Sosnowski, W. Ying, G.P. Siegal, A. Baird, J.A. Campain, and D.T. Curiel Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor Cancer Res. 57 1997 1447 1451
85. C. Rancourt, B.E. Rogers, B.A. Sosnowski, M. Wang, A. Piche, G.F. Pierce, R.D. Alvarez, G.P. Siegal, J.T. Douglas, and D.T. Curiel Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer Clin. Cancer Res. 4 1998 2455 2461
86. D.L. Gu, A.M. Gonzalez, M.A. Printz, J. Doukas, W. Ying, M. D'Andrea, D.K. Hoganson, D.T. Curiel, J.T. Douglas, B.A. Sosnowski, A. Baird, S.L. Aukerman, and G.F. Pierce Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice Cancer Res. 59 1999 2608 2614
87. M.A. Printz, A.M. Gonzalez, M. Cunningham, D.L. Gu, M. Ong, G.F. Pierce, and S.L. Aukerman Fibroblast growth factor 2-retargeted adenoviral vectors exhibit a modified biolocalization pattern and display reduced toxicity relative to native adenoviral vectors Hum. Gene Ther. 11 2000 191 204
88. J.L. Blackwell, C.R. Miller, J.T. Douglas, H. Li, P.N. Reynolds, W.R. Carroll, G.E. Peters, T.V. Strong, and D.T. Curiel Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma Arch. Otolaryngol. Head Neck Surg. 125 1999 856 863
89. P.N. Reynolds, K.R. Zinn, V.D. Gavrilyuk, I.V. Balyasnikova, B.E. Rogers, D.J. Buchsbaum, M.H. Wang, D.J. Miletich, W.E. Grizzle, J.T. Douglas, S.M. Danilov, and D.T. Curiel A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo Molec. Ther. 2 2000 562 578
90. H. Schneider, M. Groves, C. Muhle, P.N. Reynolds, A. Knight, M. Themis, J. Carvajal, F. Scaravilli, D.T. Curiel, N.F. Fairweather, and C. Coutelle Retargeting of adenoviral vectors to neurons using the Hc fragment of tetanus toxin Gene Ther. 7 2000 1584 1592
91. S.J. Watkins, V.V. Mesyanzhinov, L.P. Kurochkina, and R.E. Hawkins The 'adenobody' approach to viral targeting: specific and enhanced adenoviral gene delivery Gene Ther. 4 1997 1004 1012
92. S.A. Nicklin, S.J. White, S.J. Watkins, R.E. Hawkins, and A.H. Baker Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display Circulation 102 2000 231 237
93. H.J. Haisma, J. Grill, D.T. Curiel, S. Hoogeland, V.W. van Beusechem, H.M. Pinedo, and W.R. Gerritsen Targeting of adenoviral vectors through a bispecific single-chain antibody Cancer Gene Ther. 7 2000 901 904
94. J. Grill, V.W. Van Beusechem, P. Van Der Valk, C.M. Dirven, A. Leonhart, D.S. Pherai, H.J. Haisma, H.M. Pinedo, D.T. Curiel, and W.R. Gerritsen Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids Clin. Cancer Res. 7 2001 641 650
95. D.M. Nettelbeck, D.W. Miller, V. Jerome, M. Zuzarte, S.J. Watkins, R.E. Hawkins, R. Muller, and R.E. Kontermann Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105) Molec. Ther. 3 2001 882 891
96. I. Dmitriev, E. Kashentseva, B.E. Rogers, V. Krasnykh, and D.T. Curiel Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells J. Virol. 74 2000 6875 6884
97. A. Itoh, T. Okada, H. Mizuguchi, T. Hayakawa, H. Mizukami, A. Kume, M. Takatoku, N. Komatsu, Y. Hanazono, and K. Ozawa A soluble CAR-SCF fusion protein improves adenoviral vector-mediated gene transferto c-Kit-positive hematopoietic cells J. Gene Med. 5 2003 929 940
98. M. Trepel, M. Grifman, M.D. Weitzman, and R. Pasqualini Molecular adaptors for vascular-targeted adenoviral gene delivery Hum. Gene Ther. 11 2000 1971 1981
99. S.J. White, S.A. Nicklin, T. Sawamura, and A.H. Baker Identification of peptides that target the endothelial cell-specific LOX-1 receptor Hypertension 37 2001 449 455
100. S.I. Michael, J.S. Hong, D.T. Curiel, and J.A. Engler Addition of a short peptide ligand to the adenovirus fiber protein Gene Ther. 2 1995 660 668
101. V. Krasnykh, I. Dmitriev, G. Mikheeva, C.R. Miller, N. Belousova, and D.T. Curiel Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob J. Virol. 72 1998 1844 1852
102. T.J. Vanderkwaak, M. Wang, J. Gomez-Navarro, C. Rancourt, I. Dmitriev, V. Krasnykh, M. Barnes, G.P. Siegal, R. Alvarez, and D.T. Curiel An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches Gynecol. Oncol. 74 1999 227 234
103. V. Biermann, C. Volpers, S. Hussmann, A. Stock, H. Kewes, G. Schiedner, A. Herrmann, and S. Kochanek Targeting of high-capacity adenoviral vectors Hum. Gene Ther. 12 2001 1757 1769
104. K. Kasono, J.L. Blackwell, J.T. Douglas, I. Dmitriev, T.V. Strong, P. Reynolds, D.A. Kropf, W.R. Carroll, G.E. Peters, R.P. Bucy, D.T. Curiel, and V. Krasnykh Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector Clin. Cancer Res. 5 1999 2571 2579
105. N. Koizumi, H. Mizuguchi, T. Hosono, A. Ishii-Watabe, E. Uchida, N. Utoguchi, Y. Watanabe, and T. Hayakawa Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide Biochemica. Biophysica. Acta 1568 2001 13 20
106. J. Garcia-Castro, J.C. Segovia, F. Garcia-Sanchez, R. Lillo, J. Gomez-Navarro, D.T. Curiel, and J.A. Bueren Selective transduction of murine myelomonocytic leukemia cells (WEHI-3B) with regular and RGD-adenoviral vectors Molec. Ther. 3 2001 70 77
107. T.P. Cripe, E.J. Dunphy, A.D. Holub, A. Saini, N.H. Vasi, Y.Y. Mahller, M.H. Collins, J.D. Snyder, V. Krasnykh, D.T. Curiel, T.J. Wickham, J. DeGregori, J.M. Bergelson, and M.A. Currier Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells Cancer Res. 61 2001 2953 2960
108. R. Asada-Mikami, Y. Heike, S. Kanai, M. Azuma, K. Shirakawa, Y. Takaue, V. Krasnykh, D.T. Curiel, M. Terada, T. Abe, and H. Wakasugi Efficient gene transduction by RGD-fiber modified recombinant adenovirus into dendritic cells Jpn. J. Cancer Res. 92 2001 321 327
109. N. Okada, T. Saito, Y. Masunaga, Y. Tsukada, S. Nakagawa, H. Mizuguchi, K. Mori, Y. Okada, T. Fujita, T. Hayakawa, T. Mayumi, and A. Yamamoto Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells Cancer Res. 61 2001 7913 7919
110. S.A. Nicklin, D.J. Von Seggern, L.M. Work, D.C. Pek, A.F. Dominiczak, G.R. Nemerow, and A.H. Baker Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus Molec. Ther. 4 2001 534 542
111. S.A. Nicklin, K.L. Dishart, H. Buening, P.N. Reynolds, M. Hallek, G.R. Nemerow, D.J. Von Seggern, and A.H. Baker Transductional and transcriptional targeting of cancer cells using genetically engineered viral vectors Cancer Lett. 201 2003 165 173
112. N. Koizumi, H. Mizuguchi, N. Utoguchi, Y. Watanabe, and T. Hayakawa Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob J. Gene Med. 5 2003 267 276
113. A. Gaggar, D.M. Shayakhmetov, and A. Lieber CD46 is a cellular receptor for group B adenoviruses Nat. Med. 9 2003 1408 1412
114. A. Segerman, J.P. Atkinson, M. Marttila, V. Dennerquist, G. Wadell, and N. Arnberg Adenovirus type 11 uses CD46 as a cellular receptor J. Virol. 77 2003 9183 9191
115. J. Gall, A. Kass-Eisler, L. Leinwand, and E. Falck-Pedersen Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. J. Virol. 70 1996 2116 2123
116. H. Stecher, D.M. Shayakhmetov, G. Stamatoyannopoulos, and A. Lieber A capsid-modified adenovirus vector devoid of all viral genes: assessment of transduction and toxicity in human hematopoietic cells Molec. Ther. 4 2001 36 44
117. M.J. Havenga, A.A. Lemckert, J.M. Grimbergen, R. Vogels, L.G. Huisman, D. Valerio, A. Bout, and P.H. Quax Improved adenovirus vectors for infection of cardiovascular tissues J. Virol. 75 2001 3335 3342
118. P.H. Goossens, M.J. Havenga, E. Pieterman, A.A. Lemckert, F.C. Breedveld, A. Bout, and T.W. Huizinga Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber Arthritis Rheum. 44 2001 570 577
119. S.C. Stevenson, M. Rollence, J. Marshall-Neff, and A. McClelland Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein J. Virol. 71 1997 4782 4790
120. A. Segerman, N. Arnberg, A. Erikson, K. Lindman, and G. Wadell There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses J. Virol. 77 2003 1157 1162
121. K. Takayama, P.N. Reynolds, J.J. Short, Y. Kawakami, Y. Adachi, J.N. Glasgow, M.G. Rots, V. Krasnykh, J.T. Douglas, and D.T. Curiel A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism Virology 309 2003 282 293
122. P.N. Reynolds, S.A. Nicklin, L. Kaliberova, B.G. Boatman, W.E. Grizzle, I.V. Balyasnikova, A.H. Baker, S.M. Danilov, and D.T. Curiel Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo Nat. Biotechnol. 19 2001 838 842
123. B.G. Barnett, B.W. Tillman, D.T. Curiel, and J.T. Douglas Dual targeting of adenoviral vectors at the levels of transduction and transcription enhances the specificity of gene expression in cancer cells Molec. Ther. 6 3 2002 377 385
124. R. Alemany, and D.T. Curiel CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors Gene Ther. 8 2001 1347 1353
125. P. Leissner, V. Legrand, Y. Schlesinger, D.A. Hadji, M. van Raaij, S. Cusack, A. Pavirani, and M. Mehtali Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism Gene Ther. 8 2001 49 57
126. H. Mizuguchi, N. Koizumi, T. Hosono, A. Ishii-Watabe, E. Uchida, N. Utoguchi, Y. Watanabe, and T. Hayakawa CAR- or αv integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice Gene Ther. 9 2002 769 776
127. T. Smith, N. Idamakanti, H. Kylefjord, M. Rollence, L. King, M. Kaloss, M. Kaleko, and S.C. Stevenson In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor Molec. Ther. 5 2002 770 779
128. D.M. Shayakhmetov, and A. Lieber Dependence of adenovirus infectivity on length of the fiber shaft domain J. Virol. 74 2000 10274 10286
129. T. Nakamura, K. Sato, and H. Hamada Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber J. Virol. 77 2003 2512 2521
130. E. Vigne, J.F. Dedieu, A. Brie, A. Gillardeaux, D. Briot, K. Benihoud, M. Latta-Mahieu, P. Saulnier, M. Perricaudet, and P. Yeh Genetic manipulations of adenovirus type 5 fiber resulting in liver tropism attenuation Gene Ther. 10 2003 153 162
131. X. Gao, and L. Huang Cationic liposome-mediated gene transfer Gene Ther. 2 1995 710 722
132. R. Raja-Walia, J. Webber, J. Naftilan, G.D. Chapman, and A.J. Naftilan Enhancement of liposome-mediated gene transfer into vascular tissue by replication deficient adenovirus Gene Ther. 2 1995 521 530
133. J. Kreuzer, S. Denger, F. Reifers, C. Beisel, K. Haack, J. Gebert, and W. Kubler Adenovirus-assisted lipofection: efficient in vitro gene transfer of luciferase and cytosine deaminase to human smooth muscle cells Atherosclerosis 124 1996 49 60
134. A. Fasbender, J. Zabner, M. Chillon, T.O. Moninger, A.P. Puga, B.L. Davidson, and M.J. Welsh Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo J. Biol. Chem. 272 1997 6479 6489
135. Y. Ryuke, M. Mizuno, A. Natsume, and J. Yoshida Transduction efficiency of adenoviral vectors into human glioma cells increased by association with cationic liposomes Neurol. Med.-Chir (Tokyo) 40 2000 256 260
136. A. Natsume, M. Mizuno, Y. Ryuke, and J. Yoshida Cationic liposome conjugation to recombinant adenoviral vector reduces viral antigenicity Jpn. J. Cancer Res. 91 2000 363 367
137. M. Mizuno, Y. Ryuke, and J. Yoshida Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models Cancer Gene Ther. 9 2002 825 829
138. Y. Inada, A. Matsushima, M. Hiroto, H. Nishimura, and Y. Kodera Modification of proteins with polyethylene glycol derivatives Methods Enzymol. 242 1994 65 90
139. G.E. Francis, D. Fisher, C. Delgado, F. Malik, A. Gardiner, and D. Neale PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques Int. J. Hematol. 68 1998 1 18
140. Y. Yamamoto, Y. Tsutsumi, Y. Yoshioka, T. Nishibata, K. Kobayashi, T. Okamoto, Y. Mukai, T. Shimizu, S. Nakagawa, S. Nagata, and T. Mayumi Site-specific PEGylation of a lysine-deficient TNF-alpha with full bioactivity Nat. Biotechnol. 21 2003 546 552
141. C.R. O'Riordan, A. Lachapelle, C. Delgado, V. Parkes, S.C. Wadsworth, A.E. Smith, and G.E. Francis PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo Hum. Gene Ther. 10 1999 1349 1358
142. M.A. Croyle, N. Chirmule, Y. Zhang, and J.M. Wilson "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung J. Virol. 75 2001 4792 4801
143. M.A. Croyle, Q.C. Yu, and J.M. Wilson Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions Hum. Gene Ther. 11 2000 1713 1722
144. M.A. Croyle, N. Chirmule, Y. Zhang, and J.M. Wilson PEGylation of
145. A. Lieber, C. He, L. Meuse, C. Himeda, C. Wilson, and M.A. Kay Inhibition of NF-kappaB activation in combination with bcl-2 expression allows for persistence of first-generation adenovirus vectors in the mouse liver J. Virol. 72 1998 9267 9277
146. D. Stone, W. Xiong, J.C. Williams, A. David, P.R. Lowenstein, and M.G. Castro Adenovirus expression of IL-1 and NF-kappaB inhibitors does not inhibit acute adenoviral-induced brain inflammation, but delays immune system-mediated elimination of transgene expression Molec. Ther. 8 2003 400 411
147. M. Kolb, M. Inman, P.J. Margetts, T. Galt, and J. Gauldie Budesonide enhances repeated gene transfer and expression in the lung with adenoviral vectors Am. J. Respir. Crit. Care Med. 164 2001 866 872
148. M. Suga, R. Gladdy, Z. Xing, S.H. Keshavjee, and M. Liu Transplant immunosuppression enhances efficiency of adenoviral-mediated gene retransfection: inhibition of interferon-gamma and immunoglobin G Ann. Thorac. Surg. 73 2002 1092 1097
149. S. Ishimoto, K. Kawamoto, T. Stover, S. Kanzaki, T. Yamasoba, and Y. Raphael A glucocorticoid reduces adverse effects of adenovirus vectors in the cochlea Audiol. Neuro-otol. 8 2003 70 79
150. M. de Perrot, S. Fischer, M. Liu, Y. Imai, S. Martins, S. Sakiyama, T. Tabata, X.H. Bai, T.K. Waddell, B.L. Davidson, and S. Keshavjee Impact of human interleukin-10 on vector-induced inflammation and early graft function in rat lung transplantation Am. J. Respir. Cell Mol. Biol. 28 2003 616 625
151. D.J. Van Antwerp, S.J. Martin, T. Kafri, D.R. Green, and I.M. Verma Suppression of TNF-induced apoptosis by NF-κB Science 274 1996 787 789
152. C.-Y. Wang, M.W. Mayo, and A.S. Baldwin TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB Science 274 1996 784 787
153. G. Kroemer The proto-oncogene Bcl-2 and its role in regulating apoptosis Nat. Med. 3 1997 614 620
154. M.A. Kay, L. Meuse, A.M. Gown, P. Linsley, D. Hollenbaugh, A. Aruffo, H.D. Ochs, and C.B. Wilson Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver Proc. Natl. Acad. Sci. U. S. A. 94 1997 4686 4691
155. K. Jooss, L.A. Turka, and J.M. Wilson Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig Gene Ther. 5 1998 309 319
156. Y. Yang, Q. Li, H.C. Ertl, and J.M. Wilson Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses J. Virol. 69 1995 2004 2015
157. N. Somia, and I.M. Verma Gene therapy: trials and tribulations Nat. Rev. Genet. 1 2000 91 99
158. Z.L. Xu, H. Mizuguchi, T. Mayumi, and T. Hayakawa Woodchuck hepatitis virus post-transcriptional regulation element enhances transgene expression from adenovirus vectors Biochim. Biophys. Acta 1621 2003 266 271
159. Z.L. Xu, H. Mizuguchi, A. Ishii-Watabe, E. Uchida, T. Mayumi, and T. Hayakawa Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector J. Control. Release 81 2002 155 163
160. C.A. Gerdes, M.G. Castro, and P.R. Lowenstein Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo Molec. Ther. 2 2000 330 338
161. D. Pannell, and J. Ellis Silencing of gene expression: implications for design of retrovirus vectors Rev. Med. Virol. 11 2001 205 217
162. K. Mitani, and S. Kubo Adenovirus as an integrating vector Curr. Gene Ther. 2 2002 135 144
163. A. Lieber, D.S. Steinwaerder, C.A. Carlson, and M.A. Kay Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes J. Virol. 73 1999 9314 9324
164. A. Recchia, R.J. Parks, S. Lamartina, C. Toniatti, L. Pieroni, F. Palombo, G. Ciliberto, F.L. Graham, R. Cortese, N. La Monica, and S. Colloca Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector Proc. Natl. Acad. Sci. U. S. A. 96 1999 2615 2620
165. C. Zheng, J. Wang, and B.J. Baum Integration efficiency of a hybrid adenoretroviral vector Biochem. Biophys. Res. Commun. 300 2003 115 120
166. S.R. Yant, A. Ehrhardt, J.G. Mikkelsen, L. Meuse, T. Pham, and M.A. Kay Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo Nat. Biotechnol. 20 2002 999 1005
167. Z. Ivics, P.B. Hackett, R.H. Plasterk, and Z. Izsvak Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells Cell 91 1997 501 510
168. M. Cavazzana-Calvo, S. Hacein-Bey, G. de Saint Basile, F. Gross, E. Yvon, P. Nusbaum, F. Selz, C. Hue, S. Certain, J.L. Casanova, P. Bousso, F.L. Deist, and A. Fischer Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 288 2000 669 672
169. E. Check A tragic setback Nature 420 2002 116 118
170. E. Marshall Gene therapy. Second child in French trial is found to have leukemia Science 299 2003 320
171. S. Hacein-Bey-Abina, C. Von Kalle, M. Schmidt, M.P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C.S. Osborne, R. Pawliuk, E. Morillon, R. Sorensen, A. Forster, P. Fraser, J.I. Cohen, G. de Saint Basile, I. Alexander, U. Wintergerst, T. Frebourg, A. Aurias, D. Stoppa-Lyonnet, S. Romana, I. Radford-Weiss, F. Gross, F. Valensi, E. Delabesse, E. Macintyre, F. Sigaux, J. Soulier, L.E. Leiva, M. Wissler, C. Prinz, T.H. Rabbitts, F. Le Deist, A. Fischer, and M. Cavazzana-Calvo LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 Science 302 2003 415 419
172. H. Nakai, E. Montini, S. Fuess, T.A. Storm, M. Grompe, and M.A. Kay AAV serotype 2 vectors preferentially integrate into active genes in mice Nat. Genet. 34 2003 297 302
173. M. Urabe, K. Kogure, A. Kume, Y. Sato, K. Tobita, and K. Ozawa Positive and negative effects of adeno-associated virus Rep on AAVS1-targeted integration J. Gen. Virol. 84 2003 2127 2132
174. H. Leblois, C. Roche, N. Di Falco, C. Orsini, P. Yeh, and M. Perricaudet Stable transduction of actively dividing cells via a novel adenoviral/episomal vector Molec. Ther. 1 2000 314 322
175. F. Kreppel, and S. Kochanek Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors J. Virol. 78 2004 9 22
176. J.G. Gall, R.G. Crystal, and E. Falck-Pedersen Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype J. Virol. 72 1998 10260 10264
177. S. Roy, P.S. Shirley, A. McClelland, and M. Kaleko Circumvention of immunity to the adenovirus major coat protein hexon J. Virol. 72 1998 6875 6879
178. N. Morral, W. O'Neal, K. Rice, M. Leland, J. Kaplan, P.A. Piedra, H. Zhou, R.J. Parks, R. Velji, E. Aguilar-Cordova, S. Wadsworth, F.L. Graham, S. Kochanek, K.D. Carey, and A.L. Beaudet Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons Proc. Natl. Acad. Sci. U. S. A. 96 1999 12816 12821
179. W. Gao, P.D. Robbins, and A. Gambotto Human adenovirus type 35: nucleotide sequence and vector development Gene Ther. 10 2003 1941 1949
180. P. Seshidhar Reddy, S. Ganesh, M.P. Limbach, T. Brann, A. Pinkstaff, M. Kaloss, M. Kaleko, and S. Connelly Development of adenovirus serotype 35 as a gene transfer vector Virology 311 2003 384 393
181. R. Vogels, D. Zuijdgeest, R. van Rijnsoever, E. Hartkoorn, I. Damen, M.P. de Bethune, S. Kostense, G. Penders, N. Helmus, W. Koudstaal, M. Cecchini, A. Wetterwald, M. Sprangers, A. Lemckert, O. Ophorst, B. Koel, M. van Meerendonk, P. Quax, L. Panitti, J. Grimbergen, A. Bout, J. Goudsmit, and M. Havenga Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity J. Virol. 77 2003 8263 8271
182. F. Sakurai, H. Mizuguchi, and T. Hayakawa Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector Gene Ther. 10 2003 1041 1048
183. T. Nguyen, J. Nery, S. Joseph, C. Rocha, G. Carney, K. Spindler, and L. Villarreal Mouse adenovirus (MAV-1) expression in primary human endothelial cells and generation of a full-length infectious plasmid Gene Ther. 6 1999 1291 1297
184. A. Francois, N. Eterradossi, B. Delmas, V. Payet, and P. Langlois Construction of avian adenovirus CELO recombinants in cosmids J. Virol. 75 2001 5288 5301
185. P.S. Reddy, N. Idamakanti, Y. Chen, T. Whale, L.A. Babiuk, M. Mehtali, and S.K. Tikoo Replication-defective bovine adenovirus type 3 as an expression vector J. Virol. 73 1999 9137 9144
186. E.J. Kremer, S. Boutin, M. Chillon, and O. Danos Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer J. Virol. 74 2000 505 512
187. S. Moffatt, J. Hays, H. HogenEsch, and S.K. Mittal Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy Virology 272 2000 159 167
188. S.F. Farina, G.-P. Gao, Z.Q. Xiang, J.J. Rux, R.M. Burnett, M.R. Alvira, J. Marsh, H.C. Ertl, and J.M. Wilson Replication-defective vector based on a chimpanzee adenovirus J. Virol. 75 2001 11603 11613